MapLight Therapeutics, Inc. (MPLT)
6.93
+0.71
(+11.41%)
USD |
NASDAQ |
Nov 06, 16:00
7.59
+0.66
(+9.52%)
After-Hours: 20:00
MapLight Therapeutics EPS Diluted (TTM) : -5.122 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.122 |
| March 31, 2026 | -4.518 |
| December 31, 2025 | -3.668 |
| September 30, 2025 | -2.305 |
| June 30, 2025 | -2.114 |
| Date | Value |
|---|---|
| March 31, 2025 | -1.683 |
| June 30, 2024 | -1.190 |
| March 31, 2024 | -0.7462 |
| March 31, 2023 | -0.2892 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Cullinan Therapeutics, Inc. | -3.394 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Sarepta Therapeutics, Inc. | -2.898 |